Peter Ringrose

Corporate Officer/Principal chez The Foundation for Science & Technology

Profil

Peter S.
Ringrose is currently the Chairman of the Corporate Partnership Board at Pembroke College Cambridge and a Council Member at The Foundation for Science & Technology.
He previously served as the Chairman of the Biotechnology & Biological Sciences Research Council from 2003 to 2009.
He also held positions as a Director at ImClone LLC, an Independent Director at Rigel Pharmaceuticals, Inc. from 2005 to 2019, and a Director at MedImmune Ltd. in 2006.
Additionally, he served as a Non-Executive Director at Biotica Technology Ltd. from 2005 to 2013 and as a Director at Astex Therapeutics Ltd. in 2011.
He was an Independent Non-Executive Director at Innoviva, Inc. from 2010 to 2014.
Dr. Ringrose has also held positions as a Division Director-Chemotherapy at Sandoz Research Institute and as a Senior Vice President-Worldwide Drug Discovery at Pfizer Inc. from 1982 to 1996.
He was a Member of Innovate UK in 2009 and a Member of the Governors Board at the New York Academy of Sciences from 1999 to 2005.
He served as the President & Chief Scientific Officer at Bristol-Myers Squibb Pharmaceutical Research Institute from 2002 to 2002 and as the President of the Pharmaceutical Research Institute from 1997 to 2002.
Dr. Ringrose obtained his undergraduate, graduate, and doctorate degrees from the University of Cambridge.

Postes actifs de Peter Ringrose

Sociétés	Poste	Début
The Foundation for Science & Technology	Corporate Officer/Principal	-
Pembroke College Cambridge	Corporate Officer/Principal	-

Anciens postes connus de Peter Ringrose

Sociétés	Poste	Fin
THERAVANCE BIOPHARMA, INC.	Directeur/Membre du Conseil	28/04/2020
RIGEL PHARMACEUTICALS, INC.	Directeur/Membre du Conseil	22/05/2019
INNOVIVA, INC.	Directeur/Membre du Conseil	04/05/2014
Biotica Technology Ltd.	Directeur/Membre du Conseil	01/12/2013
Astex Therapeutics Ltd.	Directeur/Membre du Conseil	-